Kenneth J. Barr,John K. Maclean,Hongjun Zhang,Richard T. Beresis,Neville J. Anthony,Matthew Daniels,Blair T. Lapointe,Nunzio Sciammetta
申请号：
US14421062
公开号：
US20150218169A1
申请日:
2013.08.14
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
